HUDA ZOGHBI to Oligonucleotides, Antisense
This is a "connection" page, showing publications HUDA ZOGHBI has written about Oligonucleotides, Antisense.
Connection Strength
2.924
-
Recent advances in RNA-based therapeutics for neurodevelopmental disorders. Curr Opin Genet Dev. 2025 Jun; 92:102339.
Score: 0.856
-
Modeling antisense oligonucleotide therapy in MECP2 duplication syndrome human iPSC-derived neurons reveals gene expression programs responsive to MeCP2 levels. Hum Mol Genet. 2024 11 08; 33(22):1986-2001.
Score: 0.835
-
Antisense oligonucleotide therapy in a humanized mouse model of MECP2 duplication syndrome. Sci Transl Med. 2021 03 03; 13(583).
Score: 0.647
-
Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides. Nature. 2015 Dec 03; 528(7580):123-6.
Score: 0.449
-
Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles. JCI Insight. 2018 11 02; 3(21).
Score: 0.138